The JAK-STAT pathway: Signal transduction involved in proliferation, differentiation and transformation

Leukemia and Lymphoma

Volumn 28, Issue 5-6, 1998, Pages 459-467

  Weber Nordt, R M ^a   Mertelsmann, R ^a   Finke, J ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Differentiation; JAK STAT pathway; Signal transduction proliferation; Transformation

Indexed keywords

DNA BINDING PROTEIN; SERINE; TYROSINE;

AMINO TERMINAL SEQUENCE; CANCER CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION; CYTOSOL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0031923038     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809058353     Document Type: Review

References (80)

1. Darnell, J. E., Kerr, I. M. and Stark, G. R. (1994). JAK-STAT pathway and transcriptionsl activation in response to IFNs and other extracellular signalling proteins. Science, 264, 1415-19.
2. Ihle, J. N. and Kerr, I. M. (1995). Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet, 11, 69-74.
3. Lamer, A. C., David, M., Feldman, G. M., Igarashi, K.-L, Hackett, R. H., Webb, D. S. A., Sweitzer, S. M., Petricoin, E. F. and Finbloom, D. S. (1993). Tyrosine phosphorylation of DNA binding proteins by multiple cytokines. Science, 261, 1730-34.
4. Greenlund, A. C, Farrar, M. A., Viviano, B. L. and Schreiber, R. D. (1994). Ligand-induced IFN-gamma receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91). EMBOJ, 13, 1591-98.
5. Weber-Nordt, R. M., Riley, J. K., Greenlund, A. C., Moore, K. W., Darnell, J. E. and Schreiber, R. D. (1996). Stat3 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the Interleukin-10 receptor intracellular domain. J Biol Cliem, 271, 27954-27961.
6. Demoulin, J. B., Uyttenhove, C., Van Roost, E., DeLestre, B., Donckers, D., Van Snick, J. and Renauld, J. C. (1996). A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9. Mot & Cell Biol, 16, 4710-6.
7. Miyajima, A., Hara, T. and Kishimoto, T. (1992). Common subunits of cytokine receptors and the functional redundancy of cytokines. Trends Biochem Sei, 17, 378-82.
8. Wehinger, J., Gouilleux, F., Groner, B., Finke, J., Mertelsmann, R. and Weber-Nordt, R. M. (1996). IL-10 inducejr'DNA binding activity of three STAT proteins (Stall, Slat3, and StatS) and their distinct combinatorial assembly in the promoters of selected genes. FEES Letters, 394, 365-70..
9. Schaefer, T. S., Sanders, L. K. and Nathans, D. (1995). Cooperative transcriptional activity of Jun and Stat3 beta, a short form of Stat3. Proc Nail Acad Sei, 92, 9097-101.
10. Hemmann, U., Gerhartz, C., Heesel, B., Sasse, J., Kurapkat, G., Grotzinger, J., Wollmer, A., Zliong, Z., Darnell, J. E., Graeve, L., Heinrich, P. C. and Horn, F. (1996). Differential activation of acute phase response factor/STAT3 and STAT1 via the cytoplasmic domain of the interleukin 6 signal tranducer gpl30. II. Src homology SH2 domains define the specificity of STAT factor activation. J Biol Client, 271, 12999-3007.
11. Stancato, L. F., David, M., Carter-Su, C., Lamer, A. C. and Pratt, W. B. (996). Preassociation of STAT1 with STAT2 and STAT3 in separate signalling complexes prior to cytokine stimulation. J Biol Client, 271, 4134-7.
12. Ghislain, J. J. and Fish, E. N. (1996). Application of genomic DNA affinity chromatography identifies multiple interferonalpha-regulated Stat2 complexes. J Biol Chem, 271, 12408-13.
13. Wen, Z., Zhong, Z. and Darnell, J. E. (1995). Maximal activation of transcription by Stall and Stat3 requires both lyrosine and serine phosphorylation. Cell, 241, 1399-407.
14. David, M., Petricoin, E. Ill, Benjamin, C., Pine, R., Weber, M. J. and Larner, A. C. ( 1995). Requirement for MAP kinase (Erk2) aclivily in interferon a- and Interferon β-stimulated gene expression through STAT proteins. Science, 269, 1721-26.
15. Shuai, K., Liao, J. and Song, M. M. (1996). Enhancement of antiproliferative aclivily of gamma interferon by the specific inhibition of lyrosine dephosphorylation of Slat 1. Mol & Cell Biol, 16, 4932-41.
16. [ 16] Hou, J., Schindler, U., Henzel, W. J., Ho, T., Brasseur, M. and McKnight, S. L. (1995). An interleukin-4 induced Iranscription factor: IL-4 STAT. Science, 265, 1701-3.
17. Hou, J., Schindler, U., Henzel, W. J., Ho, T., Brasseur, M. and McKnicht, S. L. (1995). Idenlification and purification of human Slat proteins activaled in response lo interIeukin-2. Immunity, 2, 321-2S.
18. Lin, J. X., Migone, T. S., Tsang, M., Freidmann, M., Weatherbee, J. A., Zhou, L., Yamauchi, A., Bloom, E. T., Mietz, J. and John, S. ( 1995). The role of shared receptor motifs and common STAT proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15./mm»m'ry, 2, 331-36.
19. Yu, C. R., Lin, J. X., Fink, D. W., Akira, S., Bloom, E. T. and Yamauchi, A. (1996). Differential utilization of Janus-kinasesignal transducer activator of transcription signaling pathways in the stimulation of human natural killer cells by IL-2, IL-12, andIFN-alpha.y/m;mmo/, 157, 126-37.
20. Lai, C. F., Ripperger, J., Morella, K. K., Jurlander, J., Hawley, T. S., Carson, W. E., Kordula, T., Caligiuri, M. A., Hawley, R. G., Fey, G. H. and Baumann, H. (1996). Receptors for interleukin10 (IL-10) and IL-6-type cytokines use similar signaling mechanisms for inducing transcription through IL-6 response elements. J Biol Cliem, 271, 13968-75.
21. Stahl, N-, Farruggella, T. J., Boulton, T. G., Zhong, Z., Damell, J. and Yancopoulos, G. D. (1995). Choice of STATs and other substrates specified by modular tyrosine-bascd motifs in cytokine receptors. Science, 267, 1349-53.
22. Fu, X. Y. and Zhang, J. J. (1993). Transcription factor p91 interacts with the epridermal growth factor receptor and mediates activation of the c-fos gene promoter. Cell, 74, 1135-42.
23. Novak, U., Mui, A., Miyajima, A. and Paradiso, L. (1996). Formation of STATS-containing DNA binding complexes in response to colony-stimulating factor-1 and platelet-derived growth factor. J Biol Cliem, 271, 18350-4.
24. Ruff-Jamison, S., Chen, K. and Cohen, S. (1993). Induction by EGF and interferon-gamma of tyrosine phosphorylated DNA binding proteins in mouse liver nuclei. Science, 261, 1733-36.
25. Gouilleux, F., Wakao, H., Mundt, M. and Groner, B. (1994). Prolactin induces phosphorylation of Tyr694 of StatS (MGF), a prerequisite for DNA binding and induction of transcription. EMBOJ, 13, 4361-9.
26. Baumann, H., Morella, K. K., White, D. W., Demdski, M., Bailon, P. S., Kirn, H., Lai, C. F. and Tartaglia, L. A. (1996). The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc Nail Acad Sei, 93, 8374-8.
27. Finke, J., Temes, P., Lange, W., Mertelsmann, R. and Dölken, G. (1993). Expression of interleukin-10 in B lymphocytes of different origin. Leukemia, 7, 1852-57.
28. Kaplan, M. H., Sun, Y. L., Hoey, T. and Grusby, M. J. (1996). Impaired IL-12 responses and enhanced development of TH2 cells in Stat4-deficient mice. Nature, 382, 174-7.
29. Karras, J. G., Wang, Z., Coniglio, S. J., Frank, D. A. and Rothstein, T. L. (1996). Antigen-receptor engagement in B-cells induces nuclear expression of STATS and STAT6 proteins that bind and transactivate an IFN-gamma activation site. . llmmunol, 157, 39-47.
30. Nicholson, S. E., Novak, U., Ziegler, S. F. and Layton, J. E. (1995). Distinct regions of the granulocyte colony-stimulating factor receptor are required for tyrosine phosphorylation of the signaling molecules JAK2, Stat3, and p42, p44MAPK. Blood, 86, 3698-704.
31. Eilers, A., Georgellis, D., Klose, B., Schindler, C., Ziemiecki, A., Harpur, A. G., Wilks, A. F. and Decker, T. (1995). Differentiation regulated serine phosphorylation of Stall promotes GAF activation in macrophages. Mol Cell Biol, IS, 3579-85.
32. Danial, N. N., Pernis, A. and Rothman, P. B. (1995). Jak-Stat signaling induced by the v-abl oncogene. Science, 269, 1875-79.
33. Yu, C. L., Meyer, D. J., Campbell, G. S., Larner, A. C., CarterSu, C., Schwanz, J. and Jove, R. (1995). Enhanced DNA binding activity of a STAT3-related protein in cells transformed by the Src oncoprotein. Science, 269, 81-83,
34. Frank, D. A. and Varticovski, L. (1996). BCR/abl leads to the constitutive activation of Stat proteins, and shares an epitope with tyrosine phosphorylated Stats. Leukemia, 10, 1724-30.
35. Carlesso, N., Frank, D. A. and Griffin, J. D. (1996). Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. J Erp Med, 183, 811-20.
36. Shuai, K., Halpern, J., Ten Hoeve, J., Rao, X. and Sawyers, C. L. (1996). Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia. Oncogene, 13, 247-54.
37. Migone, T. S., Lin, J. X., Cereseto, J. C., Mulloy, J. C., O'Shea, J. J., Franchini, G. and Leonard, W. J, (1995). Constitutively activated Jak-Stat pathway in T-cells transformed with HTLV-1. Science, 269, 79-81.
38. Ceresa, B. P. and Pessin, J. E. (1996). Insulin stimulates the serine phosphorylation of the signal transducer and activator of transcription (STAT3) isoform. J Biol Cliem, 271, 12121-4.
39. Gotoh, A., Takahira, IL, Mantel, C., Litz-Jackson, S., Boswell, H. S. and Broxmeyer, H. E. (1996). Steel factor induces serine phosphorylation of Stat3 in human grow th factor-dependent myeloid cell lines. Blood, 88, 138-45,
40. O'Farrell, A. M., Ichihara, M., Mui, A. L. and Miyajima, A. (1996). Signalling pathways activated in a unique mast cell line where interleukin-3 supports survival and stem cell factor is required for a proliferative response. Blood, 87, 3655-68.
41. Coffer, P., Lutticken, C., van Puijenbroek, Klop-de Jonge, M., Horn, F. and Kruijer, \V. (1995). Transcriptional regulation of the junB promoter: analysis of STAT-mediated signal transduction. Oncogene, 10, 985-91.
42. Platanias, L. C., Uddin, S., Yctter, A., Sun, X. J. and White, M. F. (1996). The type I Interferon receptor mediates tyrosine phosphorylation of insulin receptor substrate 2. J Biol Cliem, 271, 278-82.
43. Bovolenta, C., Gasperini, S. and Cassatella, M. A. (1996). Granulocyte colony-stimulating factor induces the binding of STAT1 and STAT3 to the IFNgamma response region within the promoter of the Fc(gamma)RI/CD64 gene in human neutrophils. FEBS Letters, 386, 239-42.
44. Zhang, D., Sun, M., Samols, D. and Kushner, I. (1996). STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6. J Biol Cliem, 271, 9503-9.
45. Kojima, H., Nakajima, K. and Hirano, T. (1996). IL-6inducible complexes on an IL-6 response element of the junB promoter contain Stat3 and 36 kDa CRE-Iike site binding proteins. Oncogene, 12, 547-54
46. Tsukada, J., Waterman, W. R., Koyama, Y., Webb, A. C. and Auron, P. E. (1996). A vovel STAT-like factor mediates lipopolysaccharide, interleukin-l (IL-1), and IL-6 signaling and recognizes a gamma Interferon activation site-like element in the IL1B gene. Mol & Cell Dial, 16, 2183-94.
47. Yip-Schneider, M. T., Horie, M. and Broxmeyer, H. E. (1995). Transcriptional induction of pim-1 protein-kinase gene expression by interferon-gamma and posttranscriptional effects on costimulation with steel factor. Blood, 85, 3494-501.
48. Moroy, T., Grzeschiczek, A., Petzold, S. and Hartmann, K. U. (1993). Expression of a pim-I transgene accelerates lymphoproliferation and inhibits apoptosis in Ipr/lpr mice. Proc Natl AcadSci, 9Q, 10734-9.
49. Selten, G., Cuypers, H. T., Boelens, W., Robanus, M. E., Verbeek, J., Domen, J., Van, B. C. and Berns, A. (1986). The primary structure of the putative oncogene pim-1 shows extensive homology with protein kinases. Cell, 46, 603-8.
50. Sengupta, T. K-, Schmitt, E. M. and Ivashkiv, L. B. (1996). Inhibition of cytokines and JAK-STAT activation by distinct signaling pathways. Proc Natl Acad Sei, 93, 9499-504.
51. David, M., Petricoin, E. Ill and Lamer, A. C. (1996). Activation of protein kinase A inhibits Interferon induction of the Jak/Stat pathway in U266 cells. J DM Cliem, 271, 4585-8.
52. Ivashkiv, L. B., Schmitt, E. M. and Castro, A. (1996). Inhibition of transcription factor Stall activity in mononuclear cell cultures and T cells by the cyclic AMP signaling pathway. JImmunol, 157, 1415-21.
53. David, M., Zhou, G., Pine, R., Dixon, J. E. and Lamer, A. C. (1996). The SH2 domain-containing tyrosine phosphatase PPT1D is required for interferon alpha/beta-induced gene expression. J Biot Client, 271, 15862-5.
54. Tauchi, T., Feng, G. S., Shen, R., Song, H. Y., Donner, D., Pawson, T. and Broxmeyer, H. E. (1994). SH2-containing phosphotyrosine phosphatase Syp is a target of p210Bcr/Abl tyrosine kinase. J Biol Chem, 269, 15381-7.
55. David, M., Chen, H. E., Goelz, S., Lamer, A. C. and Ncel, B. G. (1995). Differential regulation of the alpha/beta interferonstimulated JAK/STAT pathway by the SH2 domain-containing tyrosione phosphatase SHPTP1. Mol & Cell Biol, 15, 7050-8.
56. Shulz, L. D., Schweitzer, P. A., Rajan, T. V., Yi, T., Ihle, J. N., Matthews, J., Thomas, M. L. and Beier, D. R. (1993). Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Heph) gene. Cell, 73 1445-54.
57. Tauchi, T., Feng, G. S., Shcn, R., Hoatlin, M., Bagby, G. C, Rabat, D., Lu, L. and Broxmeyer, H. E. (1995). Involvement of SH2-containing phosphotyrosine phosphatase Syp in erythropoietin receptor signal transduction pathways. J Biol Clie in, 270, 5631-35.
58. Fuhrer, D. K. and Yang, Y. C. (1996). Complex formation of JAK2 with PP2A, PI3K, and Yes in response to the hematopoietic cytokine IL-11. Biochem & Biophys Res Comm, 224, 289-96.
59. Kirn, T. K. and Maniatis, T. (1996). Regulation of interferongamma-activated STAT1 by the ubiquitin-proteasome pathway. Science, 273, 1717-9.
60. Cressman, D. E., Diamond, R. H. and Taub, R. (1995). Rapid activation of the STAT3 transcription complex in liver regeneration. Hepatology, 21 1443-47.
61. Eilers, A. and Decker, T. (1995). Activity of Slat transcription factors is developmentally controlled in cells of the macrophage lineage. Immunobiol, 193, 328-33.
62. Kordula, T., Ripperger, J., Morella, K. M., Travis, J. and Baumann, H. (1996). Two separate signal tranducer and activator of transcription proteins regulate transcription of serine proteinase inhibitor-3 gene in hepatic cells. J Biol Chem, 271, 6752-7.
63. Yan, R., Luo, H., Damell, J. E. and Dearolf, C. R. (1996). A JAK-STAT pathway regulates wing vein formation in Drosophila. Proc Natl Acad Sei, 93, 5842-7.
64. Chin, Y. E., Kitagawa, M., Su, W. C., You, Z. H., Iwamoto, Y. and Fu, X. Y. (1996). Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science, 272 719-22.
65. Matikainen, S., Ronni, T., Hurme, M., Pine, R. and Julkunen, I. (1996). Retinoic acid activates interferon regulatory factor-1 gene expression in myeloid cells. Blood, 88, 114-23.
66. Minami, M., Inoue, M., Wei, S., Takeda, K., Matsumoto, M., Kishimotot, T. and Akira, S. (1996). STAT3 activation is a critical step in gpl30-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc Nail Acad Sei, 93, 3963-6.
67. Nakajima, K., Yamanaka, Y., Nakae, K., Kojima, H., Ichiba, M., Kiuchi, N., Kitaoka, T., Fukada, T., Hibi, M. and Hirano, T. (1996). A central role for Stat3 in IL-6-induced regulation of growth and differentiation in Ml leukemia cells. EMBO J, 15, 3651-8.
68. Mellitzer, G., Wessely, O., Decker, T., Meinke, A., Hayman, M. J. and Beug, H. (1996). Activation of Slat 5b in erythroid progenitors correlates with the ability of ErbB to induce sustained cell proliferation. Proc Natl Acad Sei, 93, 9600-5.
69. Miyakawa, Y., Oda, A., Druker, B. J., Miyazaki, H., Handa, M., Ohashi, H. and Ikeda, Y. (1996). Thrombopoietin induces tyrosine phosphorylation of Stat3 and Stat5 in human blood platelets. Blood, 87, 439-46.
70. Ezumi, Y., Takayama, H. and Okuma, M. (1995). Thrombopoietin, c-MpI ligand, induces tyrosine phosphorylation of Tyks, JAK2, and STAT3, and enhances agonist-induced aggregation in platelets in vitro. FEES Letters, 374, 48-52.
71. Foxwell, B. M., Beadling, C., Guschin, D., Kerr, I. and Cantrell, D. (1995). InterIeukin-7 can induce the activation of JAK1, JAK3 and STATS proteins in murine T-cells. Europ J Imimmol, 25, 3041-6.
72. Wang, F., Sengupta, T. K., Zhong, Z. and Ivashkiv, L. B. (1995). Regulation of the balance of cytokine production and the signal transducer and activator of transcription (STAT) transcription factor activity by cytokines and inflammatory synovial fluids. ./£/ Med, 182, 1825-31.
73. Macchi, P., Villa, A., Gillani, S., Sacco, M. G., Frattini, A., Porta, F., Ugazio, A. G., Johnston, J. A., Candotti, F. and O'Shea, J. J. (1995). Mutations of JAK-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature, 377, 65-8.
74. Stephens, J. M., Morrison, R. F. and Pilch, P. F. (1996). The expression and regulation of STATs during 3T3-L1 adipocyte differentiation. J Biol Cliem, 271, 10441-4.
75. Weber-Nordt, R. M., Egen, C.. Wehinger, J., Ludwig, W., Gouilleux-Gruart, V., Mertelsmann, R. and Finke, J. (1996). Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr Virus (EBV)-related lymphoma cell lines. Blood, 88, 809-16.
76. Gouilleux-Gruart, V., Gouilleux, F., Dcsaint, C., Claisse, J., Capiod, J., Delobel, J., Weber-Nordt, R., Dusanter-Fourt, I., Dreyfus, F., Groner, B. and Prin, L. (1996). STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. Blood, 87, 1692-97.
77. Meydan, N., Grunberger, T., Dadi, H., Shahar, M., Arpaia, E., Lapidot, Z., Leeder, J. S., Freedman, M., Cohen, A., Gazit, A., Levitzki, A. and Roifman, C. M. (1996). Inhibition of acute lymphoblastic leukemia by a JAK-2 inhibitor. Nature, 379, 645-48.
78. Murata, T., Noguchi, P. D. and Puri, R. K. (1996). IL-13 induces phosphorylation and activation of JAK2 Janus kinase in human colon carcinoma cell lines: similarities between IL-4 and IL-13 signaling. J Imimmol, 156, 2972-8.
79. Watson, C. J. and Miller, W. R. (1995). Elevated levels of members of the Stat family of transcription factors in breast carcinoma nuclear extracts. BrJ Cancer, 71, 840-45.
80. Verfaule, C. M., McCarthy, J. B. and McGlave, P. B. (1992). Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. J Clin Invest, 90, 1232-41.